Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam

被引:8
|
作者
Hasan, Tasnim [1 ,2 ]
Thach Ngoc Pham [3 ]
Thu Anh Nguyen [2 ]
Hien Thi Thu Le [2 ]
Duyet Van Le [3 ]
Thuy Thi Dang [3 ]
Trang Dinh Van [3 ]
Yen Ngoc Pham [2 ]
Ha Viet Nguyen [2 ]
Giang Linh Tran [2 ]
Van Thi Cam Nguyen [2 ]
Thanh Trung Nguyen [2 ]
Viet Quang Truong [4 ]
Than Huu Dao [4 ]
Chung Thanh Le [5 ]
Nam Tan Truong [5 ]
Hoang Trung Vo [6 ]
Phuc Thanh Le [7 ]
Thao Thanh Nguyen [8 ]
Vinh Van Luu [8 ]
Vinh Dai Nguyen [9 ]
Toelle, Brett G. [1 ,2 ,10 ]
Marks, Guy B. [2 ,11 ]
Fox, Greg J. [1 ,2 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sydney, NSW 2006, Australia
[2] Woolcock Inst Med Res, Glebe, NSW 2037, Australia
[3] Natl Hosp Trop Dis, Hanoi 12319, Vietnam
[4] Hanoi Ctr Dis Control CDC, Hanoi 11512, Vietnam
[5] Da Nang Ctr Dis Control, Da Nang City 50213, Vietnam
[6] Quang Nam Ctr Dis Control, Quang Nam 51108, Vietnam
[7] Da Nang Lung Hosp, Da Nang City 50606, Vietnam
[8] Quang Nam Pham Ngoc Thach Hosp, Quang Nam 51110, Vietnam
[9] Hoa Vang Dist Hlth Ctr, Da Nang City 50807, Vietnam
[10] Sydney Local Hlth Dist, Sydney, NSW 2050, Australia
[11] Univ New South Wales, South Western Sydney Clin Sch, Liverpool 2170, Australia
关键词
COVID-19; SARS-CoV-2; seroprevalence; Vietnam; HEALTH-CARE WORKERS; SEROPREVALENCE; COVID-19;
D O I
10.3390/ijerph18126353
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
As a response to the coronavirus disease 2019 (COVID-19) pandemic, Vietnam enforced strict quarantine, contact tracing and physical distancing policies resulting in one of the lowest numbers of individuals infected with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) globally. This study aimed to determine the prevalence of SARS-CoV-2 antibody positivity among high-risk populations in Vietnam. A prevalence survey was undertaken within four communities in Vietnam, where at least two COVID-19 cases had been confirmed. Participants were classified according to the location of exposure: household contacts, close contacts, community members, and healthcare workers (HCWs) responsible for treating COVID-19 cases. Participants completed a baseline questionnaire and SARS-CoV-2 IgG antibodies were quantified using a commercial assay. A total of 3049 community members and 149 health care workers consented to the study. Among 13 individuals who were seropositive (0.4%), five household contacts (5/27, 18.5%), one close contact (1/53, 1.9%), and seven community members (7/2954, 0.2%) had detectable SARS-CoV-2 antibodies. All HCWs were negative for SARS-CoV-2 antibodies. Participants were tested a median of 15.1 (interquartile range from 14.9 to 15.2) weeks after exposure. Our study found a low prevalence of SARS-CoV-2 antibodies in high-risk communities and healthcare workers in communities in Vietnam with known COVID-19 cases.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India
    Kanungo, Srikanta
    Giri, Sidhartha
    Bhattacharya, Debdutta
    Kshatri, Jaya Singh
    Palo, Subrata Kumar
    Parai, Debaprasad
    Turuk, Jyotirmayee
    Praharaj, Ira
    Mansingh, Asit
    Dash, Girish Chandra
    Choudhary, Hari Ram
    Pattnaik, Matrujyoti
    Barik, Shakti Ranjan
    Mohanta, Amiya Ranjan
    Swain, Aparajita
    Mohapatra, Ira
    Sahoo, Rakesh Kumar
    Mishra, Rudra Prasanna
    Patro, Sithun Kumar
    Satapathy, Durga Madhab
    Pati, Sanghamitra
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (09): : 1255 - 1261
  • [32] Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
    Liu, Anding
    Li, Ying
    Wan, Zhengce
    Wang, Wenjie
    Lei, Xiaomei
    Lv, Yongman
    JAMA NETWORK OPEN, 2020, 3 (10)
  • [33] The prevalence of antibodies to SARS-CoV-2 among blood donors in China
    Chang, Le
    Hou, Wangheng
    Zhao, Lei
    Zhang, Yali
    Wang, Yanbin
    Wu, Linfeng
    Xu, Tingting
    Wang, Lilin
    Wang, Juan
    Ma, Jian
    Wang, Lan
    Zhao, Junpeng
    Xu, Jing
    Dong, Juan
    Yan, Ying
    Yang, Ru
    Li, Yu
    Guo, Fei
    Cheng, Wenjuan
    Su, Yingying
    Zeng, Jinfeng
    Han, Wei
    Cheng, Tong
    Zhang, Jun
    Yuan, Quan
    Xia, Ningshao
    Wang, Lunan
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [34] Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients
    Babaloo, Zohreh
    Yousefi, Mehdi
    Etemadi, Jalal
    Zangbar, Mohamad S. Soltani
    Bordbar, Shima
    Azar, Sima Abedi
    Roshangar, Leila
    Agebati, Leili
    Mahmoodpoor, Ata
    Ahmadian, Javad
    Farid, SimaShahmohamadi
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (12): : 1665 - 1665
  • [35] Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical Center
    Carter, Rickey E.
    Theel, Elitza S.
    Breeher, Laura E.
    Swift, Melanie D.
    Van Brunt, Nathan A.
    Smith, Windell R.
    Daugherty, Elizabeth A.
    Chapital, Alyssa B.
    Matson, Kathleen M.
    Bews, Katherine A.
    Johnson, Patrick W.
    Domnick, Robert A.
    Joyce, Diane E.
    Geyer, Holly L.
    Granger, Dane
    Hilgart, Heather R.
    Turgeon, Coleman T.
    Sanders, Karen A.
    Matern, Dietrich
    Nassar, Aziza
    Sampathkumar, Priya
    Hainy, Caitlin M.
    Orford, Robert R.
    Vachon, Celine M.
    Didehban, Roshanak
    Morice, William G.
    Ting, Henry H.
    Williams, Amy W.
    Gray, Richard J.
    Thielen, Kent R.
    Farrugia, Gianrico
    MAYO CLINIC PROCEEDINGS, 2021, 96 (05) : 1165 - 1174
  • [36] The prevalence of antibodies to SARS-CoV-2 among blood donors in China
    Le Chang
    Wangheng Hou
    Lei Zhao
    Yali Zhang
    Yanbin Wang
    Linfeng Wu
    Tingting Xu
    Lilin Wang
    Juan Wang
    Jian Ma
    Lan Wang
    Junpeng Zhao
    Jing Xu
    Juan Dong
    Ying Yan
    Ru Yang
    Yu Li
    Fei Guo
    Wenjuan Cheng
    Yingying Su
    Jinfeng Zeng
    Wei Han
    Tong Cheng
    Jun Zhang
    Quan Yuan
    Ningshao Xia
    Lunan Wang
    Nature Communications, 12
  • [37] Prevalence of SARS-CoV-2 antibodies in hospital employees, Central Germany
    Keller, Christian
    Chung, Ho-Ryun
    Jerrentrup, Andreas
    Feldmann, Leah
    Rohde, Cornelius
    Halwe, Sandro
    Woelfel, Friederike
    Guenther, Susanne
    Renz, Harald
    JOURNAL OF LABORATORY MEDICINE, 2022, 46 (01) : 61 - 69
  • [38] Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients
    Etemadi, Jalal
    Bordbar, Shima
    Soltani-Zangbar, Mohammad Sadegh
    Hajivalili, Mahsa
    Aghebati-Maleki, Leili
    Motavalli, Roza
    Mahmoodpoor, Ata
    Shahmohammadi-Farid, Sima
    Azar, Sima Abedi
    Niknafs, Bahram
    Roshangar, Leila
    Babaloo, Zohreh
    Heris, Javad Ahmadian
    Hosseini, Maryam
    Shareghi-Oskoue, Oldouz
    Parhizkar, Forough
    Khosroshahi, Hamid Tayebi
    Yousefi, Mehdi
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (04) : 993 - 1004
  • [39] Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers
    Allen, Niamh
    Riain, Una Ni
    Conlon, Niall
    Ferenczi, Annamaria
    Carrion Martin, Antonio Isidro
    Domegan, Lisa
    Walsh, Cathal
    Doherty, Lorraine
    O'Farrelly, Cliona
    Higgins, Eibhlin
    Kerr, Colm
    McGrath, Jonathan
    Bergin, Colm
    Fleming, Catherine
    Fitzgerald, Margaret
    de Gascun, Cillian
    Gallagher, Joan
    Igoe, Derval
    Keogan, Mary
    Noonan, Noirin
    Rian, Una Ni
    Smyth, Breda
    Fleming, Catherine
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [40] Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers
    Wang, Ralph C.
    Murphy, Charles E.
    Kornblith, Aaron E.
    Kurtz, Theodore
    Kohn, Michael A.
    ANNALS OF EMERGENCY MEDICINE, 2021, 77 (05) : 556 - 557